The new, negative 2.5% efficiency adjustment will be applied to the vast majority of Medicare payments for physician services. It was opposed by cardiology and most other medical societies. The new, negative 2.5% efficiency adjustment will be applied to the vast majority of Medicare payments for physician services. It was opposed by cardiology and most other medical societies. | | |
|
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT). Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT). | | |
|
The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting. The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting. | | |
|
|
"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted." "We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted." | | |
|
Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu. Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu. | | |
|
Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum. Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum. | | |
|
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more. B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more. | | |
|
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension. New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension. | | |
|
The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns. The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns. | | |
|
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform. Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform. | | |
|
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco. Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco. | | |
|
|
Such alternative educational experiences are growing in popularity as teaching tools that give residents a more interactive learning experience. Such alternative educational experiences are growing in popularity as teaching tools that give residents a more interactive learning experience. | | |
|
Medicare is finalizing a controversial “efficiency adjustment” and cuts related to practice expenses—both opposed by imaging groups earlier this year. Medicare is finalizing a controversial “efficiency adjustment” and cuts related to practice expenses—both opposed by imaging groups earlier this year. | | |
|
About 60% of those experiencing delays said they’ve struggled to find doctors who accept Medicare, the Radiology Business Management Association reports. About 60% of those experiencing delays said they’ve struggled to find doctors who accept Medicare, the Radiology Business Management Association reports. | | |
|
The Centers for Medicare & Medicaid Services announced a 3.26% reimbursement increase for all providers, with those enrolled in alternative payment models seeing a higher rise. The Centers for Medicare & Medicaid Services announced a 3.26% reimbursement increase for all providers, with those enrolled in alternative payment models seeing a higher rise. | | |
|
The settlement fund is being established for victims of the March 8 data breach, with a hearing to finalize the agreement scheduled for March 2026. Yale New Haven Health System denies any wrongdoing. The settlement fund is being established for victims of the March 8 data breach, with a hearing to finalize the agreement scheduled for March 2026. Yale New Haven Health System denies any wrongdoing. | | |
|
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
